Arrowhead Pharmaceuticals

ARWR · NASDAQ

$58.92+$1.69 (+2.95%)TodayMarket closed ·
Prev close $57.23

Who owns ARWR

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 46.4% of ARWR’s shares.

  • BlackRock Institutional Trust Company, N.A.9.4%
  • Avoro Capital Advisors LLC8.1%
  • Fidelity Management & Research Company LLC5.7%
  • Vanguard Portfolio Management, LLC4.5%
  • Next 6 largest institutions18.7%
  • All other shareholders53.6%
Top institutional holders of ARWR
HolderShares% of shares
BlackRock Institutional Trust Company, N.A.13.26M9.41%
Avoro Capital Advisors LLC11.36M8.06%
Fidelity Management & Research Company LLC8.04M5.71%
Vanguard Portfolio Management, LLC6.35M4.51%
Vanguard Capital Management, LLC6.11M4.34%
State Street Investment Management (US)5.69M4.04%
Norges Bank Investment Management (NBIM)3.90M2.77%
Anzalone (Christopher Richard)3.79M2.69%
Geode Capital Management, L.L.C.3.53M2.51%
Fred Alger Management, LLC3.30M2.34%

Largest mutual fund holders

Top mutual fund holders of ARWR
HolderShares% of shares
iShares Core S&P Mid-Cap ETF4.93M3.50%
Vanguard Total Stock Market Index Fund4.26M3.02%
Statens Pensjonsfond Utland3.89M2.76%
Vanguard Small-Cap Index Fund3.08M2.18%
Fidelity Growth Company Fund2.55M1.81%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders sold $3.10M (7 trades) of ARWR on the open market, with no buys.

Latest ARWR insider transactions
InsiderTypeSharesValue
PERRY MICHAEL SSale11.60K$1.01M
OLUKOTUN ADEOYE YSale2.00K$173.92K
Lu HongboSale2.97K$228.33K
Hamilton James CSale10.00K$750.00K
Apel Daniel JosephSale8.73K$627.86K
Apel Daniel JosephSale1.16K$81.51K
Apel Daniel JosephSale3.21K$224.91K

Short interest

Settled Sep 30, 2026

Shares short
10.76M
Days to cover
4.03
% of shares outstanding
7.64%
Average daily volume
2.67M
Change since last report
+16.0%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.